Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 2552

1.

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T.

Ann Intern Med. 2007 May 1;146(9):649-56.PMID: 17470833 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.

Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.

Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):47S-51S.PMID: 12960507 [PubMed - indexed for MEDLINE]Related articles

3.

Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.

Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.

Scand J Gastroenterol. 2008;43(7):849-56.PMID: 18584524 [PubMed - indexed for MEDLINE]Related articles

4.

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.

Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S; Italian Association of the Study of the Liver Disease (AISF).

Am J Gastroenterol. 2008 Aug;103(8):1966-72. Epub 2008 Jul 12.PMID: 18637087 [PubMed - indexed for MEDLINE]Related articles

5.

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.

Momosaki S, Nakashima Y, Kojiro M, Tabor E.

J Viral Hepat. 2005 May;12(3):325-9.PMID: 15850475 [PubMed - indexed for MEDLINE]Related articles

6.

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.

Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxì A, Ciccaglione A, Giuseppetti R, et al.

Ann Intern Med. 1992 Jan 15;116(2):97-102.PMID: 1309286 [PubMed - indexed for MEDLINE]Related articles

7.

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.

Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T.

Gut. 1999 Aug;45(2):284-8.PMID: 10403743 [PubMed - indexed for MEDLINE]Related articlesFree article

8.

Summaries for patients. Does exposure to hepatitis B virus increase the risk for liver cancer in patients with hepatitis C infection?

[No authors listed]

Ann Intern Med. 2007 May 1;146(9):I59. No abstract available. PMID: 17470828 [PubMed - indexed for MEDLINE]Related articlesFree article

9.

Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.

Tanaka K, Nagao Y, Ide T, Kumashiro R, Sata M.

Int J Mol Med. 2006 May;17(5):827-32.PMID: 16596267 [PubMed - indexed for MEDLINE]Related articles

10.

[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]

Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.

Korean J Hepatol. 2008 Mar;14(1):67-76. Korean. PMID: 18367859 [PubMed - indexed for MEDLINE]Related articlesFree article

11.

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.

Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A.

Cancer. 1994 Nov 1;74(9):2442-8.PMID: 7922998 [PubMed - indexed for MEDLINE]Related articles

12.

Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.

Tanaka H, Tsukuma H, Kasahara A, Hayashi N, Yoshihara H, Masuzawa M, Kanda T, Kashiwagi T, Inoue A, Kato M, Oshima A, Kinoshita Y, Kamada T.

Int J Cancer. 2000 Sep 1;87(5):741-9.PMID: 10925370 [PubMed - indexed for MEDLINE]Related articles

13.

Impact of interferon-alpha therapy on the development of hepatocellular carcinoma in patients with liver cirrhosis: results of an international survey.

Bonino F, Oliveri F, Colombatto P, Brunetto MR.

J Viral Hepat. 1997;4 Suppl 2:79-82.PMID: 9429213 [PubMed - indexed for MEDLINE]Related articles

14.

The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C.

Myers RP, Thibault V, Poynard T.

J Viral Hepat. 2003 Mar;10(2):103-10.PMID: 12614466 [PubMed - indexed for MEDLINE]Related articles

15.

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.

Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G.

N Engl J Med. 1999 Jul 1;341(1):22-6.PMID: 10387938 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, Novelli V, Cipolla A, Fabbri C, Pezzoli A, Roda E.

J Hepatol. 1996 Feb;24(2):141-7.PMID: 8907566 [PubMed - indexed for MEDLINE]Related articles

17.

Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.

Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.

J Gastroenterol Hepatol. 2005 May;20(5):746-51.PMID: 15853989 [PubMed - indexed for MEDLINE]Related articles

18.

Association of hepatitis C virus with liver cirrhosis and hepatocellular carcinoma compared with hepatitis B virus in Egyptian patients.

Darwish MA, Amer AF, El-Moeity AA, Darwish NM.

J Egypt Public Health Assoc. 1997;72(5-6):569-89.PMID: 17214153 [PubMed - indexed for MEDLINE]Related articles

19.

Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.

Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. Epub 2007 Jun 7.PMID: 17559381 [PubMed - indexed for MEDLINE]Related articles

20.

Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study.

Dutta U, Byth K, Kench J, Khan MH, Coverdale SA, Weltman M, Lin R, Liddle C, Farrell GC.

Aust N Z J Med. 1999 Jun;29(3):300-7.PMID: 10868491 [PubMed - indexed for MEDLINE]Related articles

Supplemental Content

Find related data

Recent activity